Showing results (131-140 of 1,687) with videos related to
Sort By:
Pageof 169
Therapeutic Advances in Medical Oncology|May 31, 2016
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapyHelena Verdaguer, Josep Tabernero, Teresa MacarullaAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in OncologyElena Garralda, Rodrigo Dienstmann, Josep TaberneroMolecular Oncology|August 2, 2014
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the testRodrigo Dienstmann, Jordi Rodon, Josep TaberneroExpert Opinion on Emerging Drugs|November 24, 2021
Emerging biological drugs for the treatment of gastroesophageal adenocarcinomaMaria Alsina, Marc Diez, Josep TaberneroCancers|March 25, 2022
Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and BeyondMaria Alsina, Josep Tabernero, Marc DiezJournal of Cancer|October 13, 2018
Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasisMiho Kono, Takeo Fujii, Naoko Matsuda, et al.Journal of the American Medical Informatics Association : JAMIA|April 17, 2014
Attitudes regarding privacy of genomic information in personalized cancer therapyDeevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, et al.Human Pathology|July 28, 2019
HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological featuresQingqing Ding, Hui Chen, Bora Lim, et al.Oncotarget|May 15, 2015
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?Fanny Le Du, Bedrich L Eckhardt, Bora Lim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2024
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 PatientsFunda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.Pageof 169